MENU
RVMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Revolution Medicines (RVMD) Ownership - Who owns Revolution Medicines?
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways... Show more
Profile
Industry
N/A
Address
700 Saginaw Drive
Phone
+1 650 481-6801
Employees
378
Web
https://www.revmed.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.17B
P/E Ratio
N/A
Total Cash
2.29B
Projected Growth
N/A
Total Debt
135.84M
Revenue
N/A
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash/Share
12.31
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
RVMD
Capitalization
7.17B
P/E Ratio
N/A
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash
2.29B
Total Cash/Share
12.31
Total Debt
136M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
2.27B
P/B Ratio
3.17
Cash Flow
N/A
Earnings
-3.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
18K
Current Ratio
14.20
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-677.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-25.98
Shares Held By Institutions
13.4B
Shares Outstanding - Current
186M
Total Liabilities
293M
Total Volume MTD
N/A
Value
-1
Gain YTD
-11.363
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
an oncology company, which focused on developing novel targeted therapies and engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
700 Saginaw Drive
Phone
+1 650 481-6801
Employees
378
Web
https://www.revmed.com